Epidemiology of breast cancer in women based on diagnosis data from oncologists and senologists in Algeria
Autor: | D Yekrou, K Rekai, H Zidane, M Oukkal, N Ameziane, A Haddouche, H Aris, S Ghomari, F Mechiat, F Smaili, A Bentouati, A Chirouf, A Ammari, C Sedkaoui, H Djedi, W Benbrahim, H Mahfouf, T Filali, A Bensalem, S Talha, A Boushaba, A Rabah, F Benabdallah, MA Saidi, M Abid, A Ladjeroud, M Kedar, N Azzouz, A Moussei, A Bendib, H Tadjerouni, N Benzidane, F Benmehidi, F Hadjam, A Bounedjar, S Mesli, N Kouadri, M Abada, R Reggad, R Larhbali, N Djehal, K Bouzid, S Saidi, S Djeghim, K Boualga, S Braikia, A Badaoui, A Abdelouahab, A Dib, F Bereksi-Reguig, B Larbaoui, M Hikem, A Boudjella, A Amber |
---|---|
Rok vydání: | 2020 |
Předmět: |
Cancer Research
medicine.medical_specialty Pediatrics medicine.medical_treatment Breast Neoplasms 03 medical and health sciences Breast cancer 0302 clinical medicine Diagnosis Epidemiology medicine Humans 030212 general & internal medicine Mortality Family history Adverse effect Prospective cohort study RC254-282 Oncologists Chemotherapy business.industry Incidence Mortality rate Incidence (epidemiology) Neoplasms. Tumors. Oncology. Including cancer and carcinogens Middle Aged medicine.disease Treatment Serology Oncology Algeria 030220 oncology & carcinogenesis Female business |
Zdroj: | Cancer Treatment and Research Communications, Vol 25, Iss, Pp 100220-(2020) |
ISSN: | 2468-2942 |
Popis: | Background Breast cancer (BC) is a major health issue threatening women's life. No reliable epidemiological data on BC diagnosed by oncologists/senologists are available in Algeria. Methods The BreCaReAl study, a non-interventional prospective cohort study, included adult women with confirmed BC in Algeria. Disease incidence, patients and disease characteristics, treatment patterns, and mortality rate were recorded up to 12 months of follow-up. Results Overall, 1,437 patients were analysed: median age was 48 [41;57] years and 337 (23.5%) women had a family history of BC. BC incidence was 22.3 (95% CI: 21.5; 23.2) cases per 100,000 inhabitants over 8 months. Delayed diagnosis was reported in 400 (29.2%) patients. First line of treatments were mainly chemotherapy and surgery. Twenty-eight serious adverse events were reported including 10 (37.0%) events which led to death. Mortality rate reached 3.2% at 12 months Conclusion A delayed diagnosis highlights the importance of implementing more effective screening strategies. |
Databáze: | OpenAIRE |
Externí odkaz: |